The central risk is not demand shortfall but under-monetization of scarcity. If
Calpine integration is messy, nuclear uptime slips,
large-load contracts arrive later or at lower premiums, or regulators slow
Crane and remedy completion, Constellation can still grow earnings while the stock de-rates from a premium starting valuation.